Login
$PVLA
$144.90 +$0.30 (0.21%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Wesley H. Kaupinen Also a director
President, Chief Executive Officer and Director
48 Not stated $3,404,904
Matthew E. Korenberg
Chief Financial Officer, Treasurer and Secretary
Not stated Not stated $1,971,437
Kathleen Goin
Chief Operating Officer
Not stated Since 2024
2 years
$1,979,837
Jeffrey Martini
Chief Scientific Officer
Not stated Since 2024
2 years
Not reported
Ashley Kline
Chief Commercial Officer
Not stated Since 2025
1 year
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 30, 2026 · updated by the 8-K of Jun 30, 2026

Directors
8
serving now
Independent
1 of 2
stated in the proxy; 6 not stated
Average tenure
2.9 years
from year joined
Director Age On board Independent Committees Other public boards 2025 pay Source
Wesley H. Kaupinen
48 2024
2 years
Not independent None stated None stated Paid as CEO
George M. Jenkins
74 2024
2 years
Not stated
Audit · Chair Compensation
None stated $303,255
Todd C. Davis
65 2024
2 years
Not stated
Compensation · Chair Nominating and Corporate Governance
Ligand Pharmaceuticals Incorporated, Pelthos Therapeutics Inc. $269,755
John Doux
57 2026
this year
Not stated None stated None stated Not stated
Christopher Kiritsy
61 2016
10 years
Not stated
Audit Nominating and Corporate Governance
None stated $267,255
Elaine J. Heron, Ph.D.
78 2024
2 years
Not stated
Audit Nominating and Corporate Governance · Chair
Vaxart, Inc. $271,255
Tadd S. Wessel
50 2024
2 years
Not stated
Compensation Nominating and Corporate Governance
None stated $264,755
Matthew Pauls Joined Jun 29, 2026
- - Independent - - -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

2 disclosed in the proxy filed Apr 30, 2026
BVF
held more than 5% of Pieris’ voting securities
Amount not stated

BVF, with other PIPE Investors, agreed to purchase approximately 3,154,241 shares of Pieris common stock and/or Pre-Funded Warrants in the PIPE Financing under a Purchase Agreement dated July 23, 2024

With Pieris Open in proxy
Directors and executive officers of Pieris
directors and executive officers of Pieris
Amount not stated

Indemnification agreements between Pieris and each of its directors and executive officers

With Pieris Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support